✓ Medically reviewed by · Last reviewed: May 2026
Pharmacy Researcher · 8 years experience
Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.
- Finacea is a 15 % azelaic acid topical gel. The US FDA has approved it for the inflammatory papules and pustules of mild-to-moderate rosacea. It is widely used off-label for acne and post-inflammatory hyperpigmentation.
- Azelaic acid works in three useful ways: it’s anti-inflammatory, antibacterial against the C. acnes bacterium, and reduces melanin production — which is why it helps both active inflammation and the marks it leaves behind.
- Typical use is a thin layer, twice daily, on cleansed skin. It is gentler than benzoyl peroxide and does not cause photosensitivity like tretinoin or hydroquinone.
- The most common side effects are burning, stinging, tingling, and mild dryness in the first weeks — usually transient. Significant skin irritation, breathing problems, or facial swelling warrant stopping and seeking review.
- It is safe in pregnancy and breastfeeding — an advantage over retinoids and hydroquinone for skin-of-colour concerns — and is considered pregnancy category B.
What is Finacea?
Finacea is the brand name for a 15 % azelaic acid topical preparation made by Bayer. It comes in two formulations: a clear gel and a foam. Azelaic acid itself is a naturally occurring dicarboxylic acid produced by Malassezia furfur, a yeast that lives on human skin, and found in small amounts in wheat, rye, and barley.
In skincare, azelaic acid is valued because it works on multiple problems at once — inflammation, bacteria, and pigmentation — with a side-effect profile that’s gentler than most of the other options in the same therapeutic areas. On this site, Aziderm Cream is a 20 % azelaic acid preparation that serves the same clinical purposes as Finacea at a more accessible price point; note the strength difference (20 % vs 15 %) is clinically modest but real.
How azelaic acid works
Three mechanisms are relevant to its clinical uses:
- Anti-inflammatory action. Azelaic acid reduces production of reactive oxygen species and suppresses inflammatory cytokines in skin cells. This dampens the redness, papules, and pustules that characterise rosacea and inflammatory acne.
- Antibacterial effect. It inhibits Cutibacterium acnes (formerly Propionibacterium acnes), the bacterium associated with acne vulgaris, without the resistance concerns of long-term topical antibiotic use.
- Tyrosinase inhibition. Azelaic acid inhibits the enzyme tyrosinase, which is critical for melanin production. This is why it helps fade post-inflammatory hyperpigmentation and melasma, particularly in darker skin tones where these marks are more persistent.
It also has mild comedolytic activity — helping clear the plugged pores that start the acne cycle — though not as pronounced as tretinoin.
Finacea for rosacea
This is the FDA-approved indication. Finacea 15 % gel (and foam) is approved for the papulopustular subtype of rosacea — the one characterised by small red bumps and pus-filled pimples on the central face.
In clinical trials, twice-daily application of 15 % azelaic acid gel for 12 weeks produced:
- Significant reduction in inflammatory lesions compared with vehicle
- Meaningful improvement in erythema (facial redness) in a proportion of patients
- An “investigator global assessment” of clear or almost-clear skin in roughly 30–40 % of users
Rosacea is a chronic condition, so azelaic acid is typically used long-term. Stopping treatment usually leads to gradual recurrence of lesions within weeks to months.
Who responds well
Patients with papulopustular rosacea — active bumps and pustules — respond best. Those with predominantly telangiectatic (visible blood vessel) rosacea see less benefit from azelaic acid alone and often need adjunctive treatment (vascular laser, brimonidine gel for flushing).
Finacea for acne
Although Finacea isn’t FDA-approved for acne, azelaic acid at 15–20 % is widely and effectively used off-label for the condition. The American Academy of Dermatology recognises it as a reasonable option, particularly in:
- Mild to moderate inflammatory acne
- Acne in pregnancy (where tretinoin is contraindicated)
- Acne with post-inflammatory hyperpigmentation (where it addresses both problems at once)
- Patients who cannot tolerate stronger agents like benzoyl peroxide or tretinoin
- Dermatosis Papulosa Nigra and adult female acne with marks
For severe nodulocystic acne, azelaic acid is usually not enough on its own and is combined with other therapies (benzoyl peroxide, oral antibiotics, hormonal therapy, or isotretinoin).
Finacea for post-inflammatory hyperpigmentation and melasma
Because azelaic acid inhibits tyrosinase, it’s useful for pigmentation problems — particularly:
- Post-inflammatory hyperpigmentation (PIH) — the dark marks left after acne lesions, ingrown hairs, or scratches, especially prominent in Fitzpatrick skin types IV–VI.
- Melasma — stubborn pigmentation, often on the cheeks and upper lip, associated with pregnancy or hormonal changes.
Unlike hydroquinone, azelaic acid does not cause rebound darkening when stopped, is not toxic to melanocytes, and is safe for extended use.
How to apply Finacea
- Clean your face with a gentle, non-soap cleanser (e.g. Cetaphil, CeraVe) and pat dry. Wait 5 minutes so skin is completely dry — wet skin increases stinging.
- Apply a thin layer to the affected areas — a pea-size amount for the full face. More is not better; excess increases irritation without improving efficacy.
- Use twice daily — morning and evening. For those prone to irritation, once daily at night for the first two weeks, then building up to twice daily.
- Follow with moisturiser if you tolerate the product but feel dry. A gentle, non-comedogenic moisturiser helps reduce irritation without blocking absorption.
- Use sunscreen (SPF 30+) each morning. While azelaic acid itself is not photosensitising, rosacea and acne skin benefits significantly from daily sun protection.
- Be patient. Rosacea and acne improvements appear by 4–8 weeks. Reassess at 12 weeks — if there’s no meaningful improvement by then, consult your dermatologist about adding or switching therapy.
What to avoid while using Finacea
- Avoid applying to broken, abraded, or sunburned skin.
- Avoid contact with eyes, mouth, and nostrils.
- Avoid using alongside strong exfoliants (glycolic acid, salicylic acid scrubs) in the same routine — combine only with guidance, as irritation is additive.
- Avoid occlusive bandaging or heavy greasy products immediately after application.
Side effects
Common and usually transient (first 2–4 weeks)
- Burning, stinging, or tingling on application — reported in roughly 29 % of users, usually resolves as skin adjusts
- Dryness, scaling, or mild peeling — reported in about 8 %
- Itching — about 11 %
- Redness or irritation — about 4 %, often worse if applied to damp skin or broken skin
Uncommon
- Allergic contact dermatitis — rare; stop if significant rash or worsening redness develops
- Worsening of asthma in predisposed individuals — avoid breathing in aerosol foam applications
- Isolated reports of hypopigmentation (light patches) on darker skin types — usually seen with long-term higher-strength use
Rare but serious
- Angioedema (facial, eye, or lip swelling) or urticaria (hives) — stop immediately and seek medical care
- Severe skin irritation that doesn’t settle after reducing frequency
The irritation most users experience in the first weeks can often be managed by:
- Reducing to once daily (or every other day) until tolerance builds
- Applying a moisturiser 10 minutes before Finacea (the “buffer” technique)
- Avoiding active ingredients (retinoids, acids) in the same routine initially
- Waiting for skin to fully dry before applying
Pregnancy and breastfeeding
Azelaic acid is one of the few acne and pigmentation treatments considered safe to continue during pregnancy. It is pregnancy category B — animal studies have not shown harm, and there’s no evidence of fetal toxicity in human use. Systemic absorption after topical application is minimal (around 4 %), so clinically meaningful exposure to the fetus is considered very low.
It is also considered compatible with breastfeeding. For mothers using it on the face, hands, or chest, applying after feeding and ensuring it’s dry before direct skin contact with the baby is sensible practice.
Pregnancy-safe alternatives in the same therapeutic areas are limited — tretinoin and hydroquinone are generally avoided — which makes azelaic acid particularly valuable for women who need ongoing acne or pigmentation treatment through pregnancy.
Alternatives and generics
| Option | Strength | Notes |
|---|---|---|
| Finacea gel (Bayer, US) | 15 % | Brand, FDA-approved for rosacea |
| Skinoren cream (Bayer, international) | 20 % | Common outside the US for acne and pigmentation |
| Aziderm Cream | 20 % | Indian generic azelaic acid, cost-effective option |
| Generic azelaic acid 10 % (cosmetic) | 10 % | OTC strength, less potent but more tolerable |
For acne, other options include benzoyl peroxide (better bactericidal but more irritating), tretinoin (better comedolytic but retinoid-level side effects), and combination products. For pigmentation, hydroquinone 4 %, tranexamic acid, and cysteamine creams are considered.
Frequently asked questions
What is Finacea used for?
FDA-approved for the inflammatory papules and pustules of mild-to-moderate rosacea. Widely used off-label for acne and post-inflammatory hyperpigmentation. The active ingredient, 15 % azelaic acid, works against multiple targets — inflammation, bacteria, and pigmentation.
How long does Finacea take to work?
Expect visible improvement in rosacea or acne by 4–8 weeks of twice-daily use. Maximum benefit typically emerges at 12 weeks. For pigmentation problems, expect slower results — 8–12 weeks for noticeable fading.
Is Finacea the same as azelaic acid?
Finacea is one brand of 15 % azelaic acid gel/foam, made by Bayer. Other preparations of azelaic acid (e.g. Aziderm 20 %, Skinoren 20 %, generic 10 % OTC) are the same active ingredient at varying strengths.
Can I use Finacea during pregnancy?
Yes — azelaic acid is pregnancy category B and is considered safe during pregnancy and breastfeeding. It is one of the few acne treatments compatible with pregnancy.
Does Finacea help with dark spots and melasma?
Yes — through its inhibition of tyrosinase. It’s particularly useful in darker skin types and in patients who need a safer alternative to hydroquinone.
Can I use Finacea with tretinoin or benzoyl peroxide?
Combinations are possible but irritation is additive. A common approach: tretinoin at night, Finacea in the morning. Or alternate days. Your dermatologist can tailor the routine. Never apply two actives wet on wet — always pat dry between.
Why does Finacea burn when I put it on?
Mild burning or stinging is very common in the first 2–4 weeks, especially if skin is damp or sensitive. Pat dry before applying, use a pea-size amount, and consider buffering with moisturiser first. If burning remains severe after 2 weeks, reduce frequency or switch to a lower-strength preparation.
Can men use Finacea?
Yes — there are no sex-specific contraindications. Rosacea, acne, and pigmentation concerns affect men and respond to azelaic acid in the same way.
Does Finacea bleach the skin?
It reduces excess melanin production but does not cause general skin lightening in the way that hydroquinone can. Hypopigmentation (lighter patches) has been reported rarely, mostly with high-strength long-term use in darker skin types.
Can I use Finacea forever?
Yes. Azelaic acid has an excellent long-term safety profile and is often used for years for chronic rosacea or persistent pigmentation. Unlike hydroquinone or long-term topical antibiotics, there are no cumulative-dose concerns.
Written by
Sophie ChenPharmaceutical Content Researcher · 8 years experience
Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.